ETIDX
Price
$19.82
Change
+$0.05 (+0.25%)
Updated
Sep 5 closing price
Net Assets
1.22B
VIMSX
Price
$79.00
Change
-$0.11 (-0.14%)
Updated
Sep 5 closing price
Net Assets
199.16B
Interact to see
Advertisement

ETIDX vs VIMSX

Header iconETIDX vs VIMSX Comparison
Open Charts ETIDX vs VIMSXBanner chart's image
Eventide Dividend Growth I
Price$19.82
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets1.22B
Vanguard Mid Cap Index Investor
Price$79.00
Change-$0.11 (-0.14%)
VolumeN/A
Net Assets199.16B
ETIDX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETIDX vs. VIMSX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETIDX is a Buy and VIMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. ETIDX (1.22B). VIMSX pays higher dividends than ETIDX: VIMSX (1.35) vs ETIDX (0.67). ETIDX was incepted earlier than VIMSX: ETIDX (8 years) vs VIMSX (27 years). ETIDX (0.96) is less costly to investors than VIMSX (0.17). ETIDX is a more actively managed with annual turnover of: 38.00 vs. VIMSX (16.00). VIMSX has a lower initial minimum investment than ETIDX: VIMSX (3000) vs ETIDX (100000). VIMSX annual gain was more profitable for investors over the last year : 15.02 vs. ETIDX (8.18). ETIDX return over 5 years is better than : 75.79 vs. VIMSX (64.92).
ETIDXVIMSXETIDX / VIMSX
Total Expense Ratio0.950.17559%
Annual Report Gross Expense Ratio0.960.17565%
Fund Existence8 years27 years-
Gain YTD6.4509.67967%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.22B199B1%
Annual Yield % from dividends0.671.3550%
Returns for 1 year8.1815.0254%
Returns for 3 years44.3141.01108%
Returns for 5 years75.7964.92117%
Returns for 10 yearsN/A140.93-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYPMY4.220.07
+1.57%
Hypera SA
BDRL0.03N/A
N/A
Blonder Tongue Laboratories, Inc.
JWCTF0.66N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.
AEOXF136.17-1.56
-1.13%
Aeroports de Paris ADP
PGZFF0.09N/A
-5.00%
Pan Global Resource, Inc.